United Asset Strategies, Inc. Halozyme Therapeutics, Inc. Transaction History

United Asset Strategies, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$31.82 - $40.75 $873,968 - $1.12 Million	-27,466 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$38.47 - $46.42 $233,282 - $281,490	6,064 Added 28.33%	27,466 $1.12 Million
Q2 2021 Jul 19, 2021	BUY	$38.84 - $51.31 $89,370 - $118,064	2,301 Added 12.05%	21,402 $972,000
Q1 2021 Apr 27, 2021	BUY	$39.51 - $51.45 $754,680 - $982,746	19,101 New	19,101 $796,000

541

123M

395K

172K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.99B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on United Asset Strategies, Inc. with notifications on news.